Industry News
Luteolin, A Plant Flavonoid, Blocks Cell Signaling Pathways In Colon Cancer Cells
Jan 23, 2012
Luteolin is a flavonoid commonly found in fruit and vegetables. This compound has been shown in laboratory conditions to have anti-inflammatory, anti-oxidant and anti-cancer properties but results from epidemiological studies have been less certain... Read More
Potential Key To Immune Suppression In Cancer Revealed By Study
Jan 23, 2012
In a study investigating immune response in cancer, researchers from Moffitt Cancer Center in Tampa, Fla... Read More
Novel Imaging Platform Enables Researchers To Engineer A Switch To Tame Aggressive Cancers
Jan 23, 2012
When cancers become aggressive and spread they are the most deadly. Unfortunately, little is known about how to stop this development. A new imaging platform developed by Lawson Health Research Institute's Drs. Ann Chambers and John Lewis is providing insight into just that - the exact moment when cancer cells turn deadly... Read More
How Protein In Teardrops Annihilates Harmful Bacteria
Jan 23, 2012
A disease-fighting protein in our teardrops has been tethered to a tiny transistor, enabling UC Irvine scientists to discover exactly how it destroys dangerous bacteria. The research could prove critical to long-term work aimed at diagnosing cancers and other illnesses in their very early stages... Read More
Chemists Unlock Potential Target For Drug Development
Jan 23, 2012
A receptor found on blood platelets whose importance as a potential pharmaceutical target has long been questioned may in fact be fruitful in drug testing, according to new research from Michigan State University chemists. A team led by Dana Spence of MSU's Department of Chemistry has revealed a way to isolate and test the receptor known as P2X1... Read More
Mechanism Of Lung-Cancer Drug Resistance Revealed By Study
Jan 23, 2012
New research published in Nature Medicine indicates that targeted drugs such as gefitinib might more effectively treat non-small cell lung cancer if they could be combined with agents that block certain microRNAs. The study was led by investigators with the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J... Read More
Discovery Of High Risk Oesophageal Cancer Gene
Jan 22, 2012
New research from Queen Mary, University of London has uncovered a gene which plays a key role in the development of oesophageal cancer (cancer of the gullet). The researchers studied families who suffer a rare inherited condition making them highly susceptible to the disease and found that a fault in a single gene was responsible... Read More
In Patients With Rare Brain Tumor, Abnormal Chromosome Indicator Of Treatment And Outcome
Jan 22, 2012
A recent analysis of clinical trial results performed by the Radiation Therapy Oncology Group (RTOG) demonstrate that a chromosomal abnormality - specifically, the absence (co-deletion) of chromosomes 1p and 19q - have definitive prognostic and predictive value for managing the treatment of adult patients with pure and mixed anaplastic oligodendrogliomas... Read More
Red Wine Versus White Wine - Comparison Of Effects On Hormones Related To Breast Cancer Risk
Jan 22, 2012
Aromatase inhibitors (AIs) prevent the conversion of androgens to estrogens, and could play a role in the development of breast cancer. This study of 36 pre-menopausal women consisted of a cross-over intervention trial to determine if there were differences between red wine and white wine in their effects on AIs... Read More
Inherited Mutation Links Exploding Chromosomes To Cancer
Jan 21, 2012
An inherited mutation in a gene known as the guardian of the genome is likely the link between exploding chromosomes and some particularly aggressive types of cancer, scientists at the European Molecular Biology Laboratory (EMBL), the German Cancer Research Centre (DKFZ) and the University Hospital, all in Heidelberg, Germany, have discovered... Read More
Previous Page Next Page